Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra

Topic: Disease mechanisms in lab and animal studies

The A4 or beta-peptide (39 to 43 amino acid residues) is the principal proteinaceous component of amyloid deposits in Alzheimer's disease. Using circular dichroism (c.d.), we have studied the secondary structures and aggregational properties in solution of 4 synthetic amyloid beta-peptides: beta-(1-28), beta-(1-39), beta-(1-42) and beta-(29-42). The natural components of cerebrovascular deposits and extracellular amyloid plaques are beta-(1-39) and beta-(1-42), while beta-(1-28) and beta-(29-42) are unnatural fragments. The beta-(1-28), beta-(1-39) and beta-(1-42) peptides adopt mixtures of beta-sheet, alpha-helix and random coil structures, with the relative proportions of each secondary structure being strongly dependent upon the solution conditions. In aqueous solution, beta-sheet structure is favored for the beta-(1-39) and beta-(1-42) peptides, while in aqueous solution containing trifluoroethanol (TFE) or hexafluoroisopropanol (HFIP), alpha-helical structure is favored for all 3 peptides. The alpha-helical structure unfolds with increasing temperature and is favored at pH 1 to 4 and pH 7 to 10; the beta-sheet conformation is temperature insensitive and is favored at pH 4 to 7. Peptide concentration studies showed that the beta-sheet conformation is oligomeric (intermolecular), whereas the alpha-helical conformation is monomeric (intramolecular). The rate of aggregation to the oligomeric beta-sheet structure (alpha-helix----random coil----beta-sheet) is also dependent upon the solution conditions such as the pH and peptide concentration; maximum beta-sheet formation occurs at pH 5.4. These results suggest that beta-peptide is not an intrinsically insoluble peptide. Thus, solution abnormalities, together with localized high peptide concentrations, which may occur in Alzheimer's disease, may contribute to the formation of amyloid plaques. The hydrophobic beta-(29-42) peptide adopts exclusively an intermolecular beta-sheet conformation in aqueous solution despite changes in temperature or pH. Therefore, this segment may be the first region of the beta-peptide to aggregate and may direct the folding of the complete beta-peptide to produce the beta-pleated sheet structure found in amyloid deposits. Differences between the solution conformations of the beta-(1-39) and beta-(1-42) peptides suggests that the last 3 C-terminal amino acids are crucial to amyloid deposition.

@article{barrow1992-1613791,
  author  = {Barrow, C. J. and Yasuda, A. and Kenny, P. T. and Zagorski, M. G.},
  title   = {{Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra}},
  journal = {Journal of molecular biology},
  year    = {1992},
  doi     = {10.1016/0022-2836(92)90106-t},
  pmid    = {1613791},
  url     = {https://doi.org/10.1016/0022-2836(92)90106-t}
}

Key findings

• Peptide concentration studies showed that the beta-sheet conformation is oligomeric (intermolecular), whereas the alpha-helical conformation is monomeric (intramolecular).
• These results suggest that beta-peptide is not an intrinsically insoluble peptide.
• Differences between the solution conformations of the beta-(1-39) and beta-(1-42) peptides suggests that the last 3 C-terminal amino acids are crucial to amyloid deposition.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1016/0022-2836(92)90106-t
• PubMed: 1613791
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Vascular contributions

• Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition Science · 1991-07-12 · usefulness score 41/100
• Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease Methods in molecular biology (Clifton, N.J.) · 2024 · usefulness score 43/100
• Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated Neuroscience letters · 2015-03-04 · usefulness score 38/100
• Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo The Journal of biological chemistry · 2004-12-07 · usefulness score 36/100
• LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms Neuron · 2004-08-01 · usefulness score 36/100
• Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis Journal of molecular biology · 2001-10-01 · usefulness score 36/100

Also tagged “presenilin”

343 studies in the library carry the topic tag “presenilin”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 343 tagged studies.

• Expression of alpha B-crystallin in Alzheimer's disease Acta neuropathologica · 1994-01-01 · usefulness score 40/100 · Biomarkers
• Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta Neuron · 2008-07-01 · usefulness score 36/100 · Vascular contributions
• Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging Neurobiology of disease · 2002-11-01 · usefulness score 36/100 · Treatments

Similar studies

• Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action 2007 · Treatments
• Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state 1993 · Inflammation and the immune system
• beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease 1993 · Vascular contributions
• Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease 2012 · Biomarkers
• Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio 2010 · Treatments
• Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta 2003 · Drug development

More on Vascular contributions

• A review that covers this ground Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis Neurology · 2011-03-01 · usefulness score 84/100
• Newest in this subject Precision Nanocrystal Theranostics for Neurodegenerative Proteopathies: Strategies to Cross the Blood-Brain Barrier and Target Protein Aggregation Preprints.org · 2026-10-26 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Depth-Dependent Alterations in Cerebral Blood and Tissue Oxygenation Associated with Tau in Alzheimer’s Disease Models bioRxiv · 2026-10-16 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Vascular contributions →